Stock MAITRI6 MAITRI ENTERPRISES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Maitri Enterprises Limited

Equities

MAITRI6

INE501L01024

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:56 01/07/2024 BST 		5-day change 1st Jan Change
26.62 INR +4.97% Intraday chart for Maitri Enterprises Limited -3.27% -29.07%
05-30 Maitri Enterprises Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
2023 Maitri Enterprises Limited Appoints Bijal Thakkar as Company Secretary and Compliance Officer Effective CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 15.35 15.79 14.72 11.12 278.7 101.2
Enterprise Value (EV) 1 15.08 14.54 14.47 13.35 331.7 160.1
P/E ratio 67.3 x 119 x 9.03 x 15.4 x 75.4 x -5,750 x
Yield - - - - - -
Capitalization / Revenue 2.24 x 0.26 x 0.22 x 0.24 x 1.39 x 0.76 x
EV / Revenue 2.2 x 0.24 x 0.21 x 0.29 x 1.65 x 1.2 x
EV / EBITDA -33.7 x -81.3 x 8.77 x 13.5 x 48.7 x 32.3 x
EV / FCF -25.8 x 3.1 x 3.46 x -4.81 x -4.5 x -48.8 x
FCF Yield -3.88% 32.2% 28.9% -20.8% -22.2% -2.05%
Price to Book 0.85 x 0.87 x 0.75 x 0.54 x 5.62 x 2.04 x
Nbr of stocks (in thousands) 1,900 1,900 1,900 1,900 4,400 4,400
Reference price 2 8.080 8.310 7.750 5.850 63.35 23.00
Announcement Date 13/08/18 03/09/19 04/09/20 03/09/21 30/08/22 06/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 6.855 61.58 68.41 45.54 200.9 133.3
EBITDA 1 -0.4467 -0.1788 1.65 0.986 6.814 4.953
EBIT 1 -0.5883 -0.4714 1.304 0.5327 5.959 4.246
Operating Margin -8.58% -0.77% 1.91% 1.17% 2.97% 3.19%
Earnings before Tax (EBT) 1 0.3098 0.2002 2.113 1.082 3.397 1.651
Net income 1 0.2315 0.1259 1.63 0.7203 2.255 -0.0108
Net margin 3.38% 0.2% 2.38% 1.58% 1.12% -0.01%
EPS 2 0.1200 0.0700 0.8579 0.3791 0.8400 -0.004000
Free Cash Flow 1 -0.5848 4.688 4.182 -2.777 -73.72 -3.282
FCF margin -8.53% 7.61% 6.11% -6.1% -36.7% -2.46%
FCF Conversion (EBITDA) - - 253.44% - - -
FCF Conversion (Net income) - 3,724.73% 256.55% - - -
Dividend per Share - - - - - -
Announcement Date 13/08/18 03/09/19 04/09/20 03/09/21 30/08/22 06/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 2.23 53 58.9
Net Cash position 1 0.28 1.25 0.26 - - -
Leverage (Debt/EBITDA) - - - 2.266 x 7.779 x 11.9 x
Free Cash Flow 1 -0.58 4.69 4.18 -2.78 -73.7 -3.28
ROE (net income / shareholders' equity) 1.3% 0.7% 8.62% 3.59% 6.44% -0.02%
ROA (Net income/ Total Assets) -1.74% -0.82% 1.67% 0.61% 3.13% 1.48%
Assets 1 -13.3 -15.26 97.65 118.4 72.12 -0.7318
Book Value Per Share 2 9.450 9.520 10.40 10.80 11.30 11.30
Cash Flow per Share 2 0.1500 0.6600 0.7300 0.9400 0.9600 1.010
Capex - 0.77 0.12 1.62 0.24 0.31
Capex / Sales - 1.26% 0.18% 3.56% 0.12% 0.23%
Announcement Date 13/08/18 03/09/19 04/09/20 03/09/21 30/08/22 06/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
MAITRI ENTERPRISES LIMITED Stock Maitri Enterprises Limited
-29.07% 1.34M
MCKESSON CORPORATION Stock McKesson Corporation
+26.64% 75.76B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-3.02% 23.95B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+15.84% 8.7B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+1.47% 8.29B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-32.22% 6.7B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+17.83% 5.38B
GALENICA AG Stock Galenica AG
+1.17% 4.08B
EBOS GROUP LIMITED Stock EBOS Group Limited
-9.44% 3.79B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
-7.80% 3.3B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. MAITRI6 Stock
  4. Financials Maitri Enterprises Limited